United Therapeutics Corp.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | 96.1% | 71.1% | 48.2% |
| Jun 2017 | 95.7% | 19.9% | -12.6% |
| Sep 2017 | 95.6% | 72.7% | 62.0% |
| Dec 2017 | 88.6% | 29.9% | 4.1% |
| Mar 2018 | 86.3% | 78.9% | 62.8% |
| Jun 2018 | 86.1% | 48.9% | 38.9% |
| Sep 2018 | 87.4% | 36.2% | 25.8% |
| Dec 2018 | 91.6% | 34.5% | 17.1% |
| Mar 2019 | 92.0% | -180.9% | -136.4% |
| Jun 2019 | 92.9% | 59.3% | 54.9% |
| Sep 2019 | 91.8% | 45.7% | 33.0% |
| Dec 2019 | 90.7% | 20.4% | 16.9% |
| Mar 2020 | 93.4% | 46.8% | 38.6% |
| Jun 2020 | 92.8% | 38.8% | 29.6% |
| Sep 2020 | 93.7% | 58.2% | 45.0% |
| Dec 2020 | 91.0% | 17.0% | 25.7% |
| Mar 2021 | 93.9% | -17.1% | 7.5% |
| Jun 2021 | 91.7% | 49.8% | 38.7% |
| Sep 2021 | 93.8% | 51.4% | 36.6% |
| Dec 2021 | 91.7% | 40.9% | 27.0% |
| Mar 2022 | 94.4% | 62.4% | 51.9% |
| Jun 2022 | 93.6% | 43.2% | 24.8% |
| Sep 2022 | 92.8% | 60.9% | 46.4% |
| Dec 2022 | 88.0% | 35.7% | 26.9% |
| Mar 2023 | 89.7% | 56.1% | 47.5% |
| Jun 2023 | 89.3% | 52.5% | 43.5% |
| Sep 2023 | 88.5% | 53.7% | 43.9% |
| Dec 2023 | 88.4% | 42.3% | 35.3% |
| Mar 2024 | 89.2% | 52.6% | 45.2% |
| Jun 2024 | 89.1% | 44.7% | 38.9% |
| Sep 2024 | 88.9% | 45.8% | 41.3% |
| Dec 2024 | 89.7% | 48.6% | 40.9% |
| Mar 2025 | 88.4% | 48.2% | 40.6% |
| Jun 2025 | 89.0% | 45.6% | 38.8% |
| Sep 2025 | 87.4% | 48.6% | 42.4% |
| Dec 2025 | 86.9% | 45.1% | 46.1% |
| Mar 2026 | 82.9% | 41.7% | 35.2% |
| Jun 2026 | 87.3% | 42.2% | 42.5% |